Consulting service, Research, Patent

Consulting services spanning different cultures and societies require meticulous communication. Our representative obtained a medical license in India and earned a Doctor of Medical Science degree in Japan. Our strength lies in our expertise in the medical fields of Japan, India, and Africa, coupled with proficiency in Japanese communication.

We help connect outstanding products and technologies with new customers and markets.

For details, please contact us via the Inquiry page.

コンサルティング、研究、特許

(GN Corporation team and collaborators in Hanoi, Vietnam)

1. Development, Clinical Application, and Patent Filing for Regenerative Medicine Technologies and Medical Devices

We provide consulting services for clinical application proposals, research plan development, and patent filing related to technological development in the regenerative medicine field.

[Project Examples]

Through joint research with a hospital, we secured Patent No. 6714247* in the regenerative medicine field. In March 2025, the first clinical application in a Japanese hospital was performed via technology transfer from India to Japan.

  *BEES-HAUS: Treatment for Male Urethral Stricture Using Cultured Cells from the Patient’s Own Oral Mucosa

For details on our research, please see the Research – Cell Therapy Development page and the Publications (Regenerative Medicine) page.

2. Coordination of Overseas Clinical Trials and Market Research

We plan clinical trials tailored to local needs, conduct market research on medical devices and instruments, and provide marketing proposals in India and Africa—regions with projected economic growth.

[Project Examples]

  • Obtaining import permits, product registration, and marketing for medical instruments in India (2018–present)
  • Market research on regenerative medicine and medical devices in India (2025)

We also develop medical devices (coatings). Please see the Research – Medical Devices & Coatings page.

3. Consulting for Research and Other Matters Related to U.S. FDA Applications

We provide proposals for creating research plans and other activities necessary for applications.

[Project Examples]

For the medical application of food additives to rare diseases, we received two designations in 2024 under the U.S. FDA’s Incentive Programs for Rare Disease Medical Products:

  • ODD (Orphan Drug Designation program)
  • RPD (Rare Pediatric Disease Priority Review Voucher program)

in 2024.

For details on our research, please see the Research – Rare Diseases & Cancer Adjuvants page and the Publications (Health Food Related) page.

4. Overseas Expansion of AIET Cancer Immunotherapy and Regenerative Medicine Treatments

We introduce Japanese cancer immunotherapy and regenerative medicine treatments using Japanese reagents overseas. We provide consulting services from establishing local facilities, training staff, and preparing equipment and reagents, all the way through to clinical implementation.

For details on our overseas expansion, please see the Research – Cell Therapy Development page.

[Project Examples]

Malaysia (2008–2012), Vietnam (2015–), Mauritius (2025–)

*The images shown are for illustrative purposes only and may differ from actual research or medical settings.

Scroll to Top